Evidence map›Paper›PMID 37650886›Full record

ArticleAnnals of hematology2023

High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.

Marcella Visentini, Andrea Pica, Giancarlo D'Ippolito, Eleonora Sculco, Francesca La Gualana, Laura Gragnani, Marzia Miglionico, Cesare Mazzaro, Massimo Fiorilli, Stefania Basili and 5 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Marcella VisentiniDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. marcella.visentini@uniroma1.it.ORCID http://orcid.org/0000-0002-4053-6091
Andrea PicaDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Giancarlo D'IppolitoDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Eleonora SculcoDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Francesca La GualanaDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Laura GragnaniDepartment of Translational Research & NTMS, University of Pisa, Pisa, Italy.ORCID https://orcid.org/0000-0001-6800-9149
Marzia MiglionicoDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Cesare MazzaroUnit of Clinical of Experimental Onco-Haematology, IRCCS Centro di Riferimento Oncologico (CRO), Aviano, Pordenone, Italy.ORCID https://orcid.org/0000-0002-0305-6574
Massimo FiorilliDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0002-2328-5710
Stefania BasiliDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0002-6987-1926
Maurizio MartelliDivision of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0003-1007-0339
Alice Di RoccoDivision of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0003-0985-9623
Milvia CasatoDivision of Clinical Immunology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0003-1841-6808
Giuseppe GentileDivision of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0002-1105-5256
Alessandro PulsoniDivision of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0001-7429-8004
Sapienza University of Rome · ITCentro di Riferimento Oncologico · ITUniversity of Pisa · IT

Funding

Sapienza Università di Roma RM11916B7567F9E4Sapienza Università di Roma RM1221816BD89873
6 · The paper itself

Abstract

Studies from high endemic areas, mostly China, indicate that surface antigen positive (HBsAg

Indexed as

Hepatitis BHepatitis B, ChronicLymphoma, Large B-Cell, DiffuseFemaleHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B virusHumansMalePrevalenceRetrospective StudiesHepatitis B AntibodiesHepatitis B Surface AntigensChronic infectionDiffuse large B-cell lymphomaHepatitis B virusPast infection

Identifiers

PMID37650886
PMCPMC10640471
OpenAlexW4386305265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.